GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 338 filers reported holding GUARDANT HEALTH INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,610 | -4.8% | 223 | +14.9% | 0.00% | 0.0% |
| Q2 2023 | $6,946 | +1038.7% | 194 | +646.2% | 0.00% | – |
| Q1 2023 | $610 | -82.9% | 26 | -80.2% | 0.00% | – |
| Q4 2022 | $3,563 | -64.4% | 131 | -28.0% | 0.00% | -100.0% |
| Q3 2022 | $10,000 | +25.0% | 182 | -5.2% | 0.00% | 0.0% |
| Q2 2022 | $8,000 | -20.0% | 192 | +30.6% | 0.00% | 0.0% |
| Q1 2022 | $10,000 | -9.1% | 147 | +37.4% | 0.00% | 0.0% |
| Q4 2021 | $11,000 | +10.0% | 107 | +32.1% | 0.00% | 0.0% |
| Q3 2021 | $10,000 | +11.1% | 81 | +17.4% | 0.00% | 0.0% |
| Q2 2021 | $9,000 | -18.2% | 69 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $11,000 | +37.5% | 69 | +13.1% | 0.00% | +100.0% |
| Q4 2020 | $8,000 | +60.0% | 61 | +35.6% | 0.00% | 0.0% |
| Q3 2020 | $5,000 | -72.2% | 45 | -79.4% | 0.00% | -75.0% |
| Q2 2020 | $18,000 | +800.0% | 218 | +626.7% | 0.00% | – |
| Q1 2020 | $2,000 | – | 30 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |